Previous 10 | Next 10 |
PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023. Fourth Quarter Highlights: Revenue was $88.0 million, compared to $86.6 million i...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
2024-02-05 14:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting January 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on Thursday, February 29 th , 2024. Company management ...
2024-01-30 11:44:17 ET Summary Certara is a major player in the biosimulation industry and has a strong position in the market. Despite recent financial challenges, Certara's overall business effectiveness remains undeniable. The company's strategic acquisitions and expansions...
TORONTO, ON / ACCESSWIRE / January 24, 2024 / Cerrado Gold Inc. (TSX.V:CERT)(OTCQX:CRDOF) ("Cerrado" or the "Company") announces production results for the fourth quarter of 2023 ("Q4 2023") from the Minera Don Nicolas Mine in Santa Cruz Province, Argentina ("MDN"). Full financial results are ...
TORONTO, ON / ACCESSWIRE / January 18, 2024 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF) ("Cerrado" or the "Company") announces in connection with the US$20 million secured note (the "Note") issued by Cerrado to Sprott Resource Streaming and Royalty Corp. ("Sprott") to facilitate funding of the ...
2024-01-11 08:30:00 ET Summary GoodRx Holdings announced preliminary financial results for Q4 2023, exceeding guidance on the top line. The company's financial performance in previous quarters has been disappointing, with declining revenue and profitability metrics. Management...
2023-12-13 16:41:11 ET More on Certara Certara, Inc. 2023 Q3 - Results - Earnings Call Presentation Certara Inc. (CERT) Q3 2023 Earnings Call Transcript Circling Back On Certara For further details see: Certara acquires Applied BioMath
PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced it has acquired Applied BioMath, an industry-leader in providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development (R&D). Tog...
News, Short Squeeze, Breakout and More Instantly...
2024-07-16 14:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed...
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2024 after the market close on Tuesday, August 6 th , 2024. Company management will...